XOMA vs GERN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

XOMA

46.3
AI Score
VS
XOMA Wins

GERN

33.0
AI Score

Investment Advisor Scores

XOMA

46score
Recommendation
HOLD

GERN

33score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric XOMA GERN Winner
Forward P/E 21.4592 0 Tie
PEG Ratio -0.42 -2.38 Tie
Revenue Growth -22.6% 17.2% GERN
Earnings Growth 207.9% 0.0% XOMA
Tradestie Score 46.3/100 33.0/100 XOMA
Profit Margin 69.6% -33.1% XOMA
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL XOMA

Relative Price Performance (Last 90 Days)

XOMA 1M: -3.8% · 3M: +9.3% GERN 1M: +4.8% · 3M: +20.6%

Current Technical Phase

XOMA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.5 · Price: $40.17

GERN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 53

RSI (14): 52.8 · Price: $1.52

Fundamentals Snapshot

Metric XOMA GERN
Market Cap
Forward P/E -803.4 38.0
Trailing P/E 28.2
Revenue (TTM)
Revenue Growth -0.2% 0.2%
Gross Margin 1.0% 0.6%
Operating Margin 0.0% -0.2%
EPS 1.57 -0.11
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XOMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.